MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-CH-01-0015552
Holly Drugs Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹21.53 Cr
▲ 34% YoY
Net profit · FY 2024
₹1.44 Lakh
Net margin 0.1%
EBITDA · FY 2024
₹27.88 Lakh
EBITDA margin 1.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹65 Lakh
Secured borrowings
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings
About Holly Drugs Private Limited
Data last updated:
Holly Drugs Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 July 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2007PTC030879. Its GSTIN is 04AABCH8895A1ZN (Chandigarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepak Batra and Manju Batra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 392 2nd Floor Sector 37D, Chandigarh, India – 160036.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.53 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹1.44 Lakh (net margin 0.1%) and EBITDA of ₹27.88 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 13% over five years.
As per MCA filings, the company has open charges of ₹65 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
Holly Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0015552). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website holly-drugs-pvt-ltd.business.site.
Company details
CIN U24232CH2007PTC030879
Registration Number 030879
Incorporation Date 18 July 2007
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-CH-01-0015552
Recognitions & Rankings of Holly Drugs
Contact details
Holly Drugs Private Limited's registered office is in Chandigarh, Chandigarh. Its website is holly-drugs-pvt-ltd.business.site. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO 392 2nd Floor Sector 37D, Chandigarh, India – 160036
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Holly Drugs Private Limited, buy the company report.
Comprehensive company report
Holly Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Holly Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Holly Drugs Private Limited, buy the company report.
Financials of Holly Drugs Private Limited
FY 2025 filings availableHolly Drugs Private Limited reported revenue of ₹21.53 Cr (up 34% YoY) for FY 2024.
Revenue · FY 2024
₹21.53 Cr ▲ 34%
Net profit · FY 2024
₹1.44 Lakh margin 0.1%
EBITDA · FY 2024
₹27.88 Lakh margin 1.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 23%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 4%
5 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 34% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Holly Drugs Private Limited, buy the company report.
Board of directors of Holly Drugs Private Limited
Holly Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manju Batra | Additional Director | 07 Oct 2024 | 2 Years 1 Months | Current |
| Deepak Batra | Director | 18 Jul 2007 | 19 Years 3 Months | Current |
Peer comparison
Holly Drugs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Trichem Healthcare Private Limited | ₹21.74 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Global Appliances Private Limited | ₹21.55 Cr (FY 2025) | 7.0% | Delhi, India | |||
| Medfill Healthcare Private Limited | ₹21.54 Cr (FY 2025) | 1.0% | Noida, Uttar Pradesh, India | |||
| Holly Drugs Private Limitedthis company | ₹21.53 Cr (FY 2024) | ₹1.44 Lakh | 0.1% | 34.0% | Chandigarh, India | |
| Saksham Technologies Private Limited | ₹21.49 Cr (FY 2025) | -11.0% | Mumbai, Maharashtra, India | |||
| Dr. Acharya Pharmaceuticals Private Limited | ₹21.44 Cr (FY 2025) | 15.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Holly Drugs Private Limited, buy the company report.
Auditor
Holly Drugs Private Limited is audited by SANJAY ARORA AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY ARORA AND ASSOCIATES | FY 2023 | 008445N |
Shareholding
The shareholding of Holly Drugs Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Holly Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹65 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Aug 2013 | 10454303 | Indian Bank | ₹40 Lakh | Open | |
| 26 Nov 2007 | 10084974 | State of India | ₹25 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Holly Drugs Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Cadila Pharma | Disposed |
To see the full case history of Holly Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Holly Drugs Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 12 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aurel Biolife |
To see the full MSME payment records of Holly Drugs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Holly Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AABCH8895A1ZN | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Holly Drugs Private Limited, buy the company report.
Recent activity
Holly Drugs Private Limited has 5 board changes on record since 2007: 3 appointments and 2 cessations. The latest: Manju Batra was appointed as Additional Director on 07 Oct 2024.
AGM
Holly Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Holly Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Manju Batra was appointed as Additional Director.
Ceased
Sahil Batra ceased to be Additional Director.
Ceased
Sandeep Batra ceased to be Director.
Appointed
Sahil Batra was appointed as Director.
Charges
A charge with Indian Bank amounted to Rs. 40.00 Lakh with Charge ID 10454303 was registered on 24 Aug 2013.
Charges
A charge with State Of India amounted to Rs. 25.00 Lakh with Charge ID 10084974 was registered on 26 Nov 2007.
Appointed
Deepak Batra was appointed as Director.
Incorporation
18 Jul 2007
Holly Drugs Private Limited was registered on 18 Jul 2007 with Roc Chandigarh & aged 19 years 3 months as per MCA records.
Frequently asked questions
Holly Drugs is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 July 2007 (19+ years old) and is registered under CIN U24232CH2007PTC030879.
Holly Drugs has 2 current directors:
- Manju Batra - Additional Director
- Deepak Batra - Director
The latest financial statements of Holly Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Holly Drugs is 04AABCH8895A1ZN, registered in Chandigarh.
The CIN (Corporate Identification Number) of Holly Drugs is U24232CH2007PTC030879. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Holly Drugs has 1 court case on record: 1 filed against it.
Holly Drugs was incorporated on 18 July 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Holly Drugs by revenue are Trichem Healthcare Private Limited, Global Appliances Private Limited, Medfill Healthcare Private Limited, Saksham Technologies Private Limited, Dr. Acharya Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Manju Batra was appointed as Additional Director on 07 Oct 2024. Sahil Batra ceased to be Additional Director on 31 Dec 2020. Sandeep Batra ceased to be Director on 31 Mar 2018. Holly Drugs has 5 board changes on record in total.
Yes, Holly Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-CH-01-0015552).
Holly Drugs has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 12 overdue payments to 1 micro and small supplier. The latest return was filed on 28 May 2019.
Holly Drugs can be reached through the website holly-drugs-pvt-ltd.business.site. Its registered office is in Chandigarh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages